pubmed-article:21401214 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C0042571 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C0231441 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C0443218 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C2827483 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C0439659 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C1959890 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:21401214 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:21401214 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:21401214 | pubmed:dateCreated | 2011-5-2 | lld:pubmed |
pubmed-article:21401214 | pubmed:abstractText | Vertigo may arise from dysfunction in the peripheral and/or the central vestibular system. Simultaneous activity of a medication at both sites will serve to improve the efficacy of antivertigo treatment. The aim of this study was to compare the efficacy and tolerability of a fixed combination of the peripherally acting cinnarizine (20?mg) plus the centrally acting dimenhydrinate (40?mg) with those of equally dosed monotherapies in the treatment of vertigo of various origins. | lld:pubmed |
pubmed-article:21401214 | pubmed:language | eng | lld:pubmed |
pubmed-article:21401214 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401214 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21401214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401214 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21401214 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21401214 | pubmed:issn | 1179-1918 | lld:pubmed |
pubmed-article:21401214 | pubmed:author | pubmed-author:BaumannWolfga... | lld:pubmed |
pubmed-article:21401214 | pubmed:author | pubmed-author:NovotnýMirosl... | lld:pubmed |
pubmed-article:21401214 | pubmed:author | pubmed-author:HahnAlesA | lld:pubmed |
pubmed-article:21401214 | pubmed:author | pubmed-author:ShotekovPenko... | lld:pubmed |
pubmed-article:21401214 | pubmed:author | pubmed-author:CirekZdenekZ | lld:pubmed |
pubmed-article:21401214 | pubmed:author | pubmed-author:Bognar-Steinb... | lld:pubmed |
pubmed-article:21401214 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21401214 | pubmed:volume | 31 | lld:pubmed |
pubmed-article:21401214 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21401214 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21401214 | pubmed:pagination | 371-83 | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:meshHeading | pubmed-meshheading:21401214... | lld:pubmed |
pubmed-article:21401214 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21401214 | pubmed:articleTitle | Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study. | lld:pubmed |
pubmed-article:21401214 | pubmed:affiliation | ENT Department, Charles University Prague, Third Medical Faculty and Faculty Hospital Krlovsk Vinohrady, Prague, Czech Republic. | lld:pubmed |
pubmed-article:21401214 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21401214 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:21401214 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:21401214 | pubmed:publicationType | Multicenter Study | lld:pubmed |